Keith Westby, SVP, Chief Operating Officer at IVERIC bio, Inc. (ISEE), sold 60,000 shares at $37.12 ($2.2M) on 2023-05-01, disclosed to the SEC on 2023-05-03.
Scheduled sale ($2.2M) by SVP, Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.12 | 8,786 | $326K | 14.6% |
| 2 | $37.12 | 8,786 | $326K | 14.6% |
| 3 | $37.12 | 11,214 | $416K | 18.6% |
| 4 | $37.12 | 11,214 | $416K | 18.6% |
| 5 | $37.81 | 20,000 | $756K | 33.7% |
| Total | $37.35 avg | 60,000 |
| $2.2M |
| 100% |
| Filing → |
| ISEE | SELL | 2023-04-25 | $1.2M | — | Filing → |
| ISEE | SELL | 2023-04-05 | $2.1M | — | Filing → |
| ISEE | SELL | 2023-03-06 | $479K | — | Filing → |